Mark Wunderlich is an accomplished inventor based in Cincinnati, OH (US). He has made significant contributions to the field of cancer therapeutics, particularly through his innovative research on hydrogen peroxide-activated compounds. His work focuses on developing selective anti-cancer treatments that target cancers associated with elevated reactive oxygen species (ROS).

Latest Patents

Mark Wunderlich holds a patent for "Hydrogen peroxide-activated compounds as selective anti-cancer therapeutics." This patent describes compounds that are activated in the presence of hydrogen peroxide, making them effective in treating cancers linked to increased ROS. The patent outlines methods and pharmaceutical compositions for targeting these specific cancers, showcasing his commitment to advancing cancer treatment options. He has 1 patent to his name.

Career Highlights

Wunderlich is affiliated with the University of Cincinnati, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to groundbreaking research in cancer therapeutics. His dedication to innovation has positioned him as a key figure in the scientific community.

Collaborations

Mark Wunderlich has worked alongside notable colleagues, including Edward J Merino and Safnas F Abdulsalam. These collaborations have further enriched his research and have led to advancements in the understanding of cancer treatment.

Conclusion

Mark Wunderlich's contributions to the field of selective anti-cancer therapeutics highlight his innovative spirit and commitment to improving cancer treatment. His work continues to inspire future research and development in this critical area of medicine.

Profile summary based on public USPTO records.